Patents Assigned to LifeCuff Technologies Inc.
  • Patent number: 11123256
    Abstract: A system for automated delivery and monitoring compliance for repeated remote ischemic conditioning treatments incudes at least one device for automated delivery of the therapy and at least one communications module to collect and record usage data. Reports of subject compliance with a predetermined schedule of therapy delivery is transmitted to the central database and a prescribing physician.
    Type: Grant
    Filed: April 25, 2021
    Date of Patent: September 21, 2021
    Assignee: LifeCuff Technologies Inc.
    Inventors: Boris Leschinsky, Thomas A Moore, Abe Abramovich
  • Patent number: 10624649
    Abstract: Methods for adaptive cuff inflation for the purposes of occluding a limb of a subject include inflating a cuff to a pressure at or above limb occlusion pressure and periodically deflating the cuff to detect amplitude of oscillometric oscillations reaching or exceeding a predetermined threshold, whereby indicating that the cuff pressure has reached an updated systolic blood pressure. Selecting the cuff to be wide enough to define limb occlusion pressure at or below the systolic blood pressure assures that this maneuver does not compromise cessation of blood flow to the limb. Devices are disclosed configured to operate in at least two of the following three operating modes: a tourniquet mode, a remote conditioning mode and a blood pressure monitoring mode.
    Type: Grant
    Filed: October 30, 2017
    Date of Patent: April 21, 2020
    Assignee: LifeCuff Technologies Inc.
    Inventor: Boris Leschinsky
  • Patent number: 9950009
    Abstract: Treatment methods are described using blood collected from a donor after subjecting thereof to remote conditioning such as remote ischemic conditioning via several episodes of short-term limb occlusion. Blood containing remote conditioning substances or a biologically active preparation containing such substances may be stored and used at a future time to afford a health benefit to the treatment subject. Extraction of remote conditioning substances may be done extracorporeally using dialysis or other blood processing methods following by returning of blood to the donor. Extraction of remote conditioning substances may be done during the time periods of their maximum presence in donor blood.
    Type: Grant
    Filed: February 13, 2017
    Date of Patent: April 24, 2018
    Assignee: LifeCuff Technologies Inc.
    Inventor: Boris Leschinsky
  • Patent number: 9801780
    Abstract: Single- or dual-bladder devices for automated delivery of remote ischemic conditioning treatment via partial limb occlusion involve various methods of operating the cuff in which partial or full limb occlusion is achieved during the periods of cuff inflation. Achieving clinical benefits of remote ischemic conditioning without extended cessation of limb blood flow are advantageous due to lower required cuff pressure and reduced risk of clot formation in the limb vasculature.
    Type: Grant
    Filed: March 18, 2015
    Date of Patent: October 31, 2017
    Assignee: LifeCuff Technologies Inc.
    Inventor: Boris Leschinsky
  • Patent number: 9610213
    Abstract: Single- or dual-bladder devices for remote ischemic preconditioning and blood pressure monitoring are disclosed along with various oscillometry-based and other methods for detecting systolic and diastolic blood pressure while the ischemic preconditioning treatment is in progress. The devices and methods of the invention provide for delivery of ischemic preconditioning at the lowest effective cuff pressure while closely monitoring patient's hemodynamics. Advantageously, the device of the invention allows both ischemic preconditioning and blood pressure monitoring to be done on the same limb. Disposable battery-powered version of the device of the present invention is especially useful for emergency use with patients suffering from acute myocardial infarction, acute stroke, or acute trauma. Additional device configurations are described for use in a percutaneous intervention and vascular sealing settings.
    Type: Grant
    Filed: June 16, 2014
    Date of Patent: April 4, 2017
    Assignee: LifeCuff Technologies Inc.
    Inventor: Boris Leschinsky
  • Patent number: 9611476
    Abstract: Cancer treatment methods comprising a step of applying remote conditioning to the cancer subject, for example remote ischemic conditioning via several episodes of short-term limb occlusion. Upregulation and release of remote conditioning substances such as microRNA 144/451 cluster endogenously caused by remote conditioning may be beneficial in reducing the growth and proliferation of malignant cells. Remote conditioning may also be beneficial when combined with chemotherapy or radiation therapy as it may improve survival of healthy surrounding tissues and minimize side effects of these known cancer treatments. Remote conditioning may be non-invasively applied by a medical professional or self-applied by the cancer subject at home using an automatic device. The novel cancer treatment methods may be used for lung cancers, liver cancers, colorectal cancers, digestive cancers and other cancers.
    Type: Grant
    Filed: September 8, 2015
    Date of Patent: April 4, 2017
    Assignee: LifeCuff Technologies Inc.
    Inventor: Boris Leschinsky